Radiology technology company Hexarad has completed a €13 million growth round, with European healthtech growth equity investor MTIP leading the round alongside reinvestment from existing shareholders, including the Foresight Group.
The London-based company's proprietary software and teleradiology platform aims to help customers across the U.K., Ireland, and Saudi Arabia to boost radiology capacity and address the key causes of diagnostic delays. Its software range covers an end-to-end radiology workflow, including a proprietary radiology information system (RIS), Hexarad Edge integration engine, Hexarad Hub for urgent reporting, and Hexarad Portal for autoallocation.
The company recently won a Health Services Journal Partnership award for its work in reducing diagnostic waiting times for acute and emergency care patients at North West Anglia NHS Foundation, U.K.
